Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 


Receive this page by email each issue: [Sign up for eTOCs]

November 2003   Volume 61, Supplement 5   [Index by Author] 
       INTRODUCTION
       ARTICLES
Find articles in this issue containing these words:
[Search ALL Issues]


To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

INTRODUCTION:

Andrew R. Pachner
Anti-IFNß antibodies in IFNß-treated MS patients: Summary
Neurology 2003 61: S1-5. [Full Text]  

ARTICLES:

Section I: Immunity to interferons and other biologicals:

Klaus Bendtzen
Anti-IFN BAb and NAb antibodies: A minireview
Neurology 2003 61: S6-10. [Full Text] [Figures Only]  

Huub Schellekens
The immunogenicity of biopharmaceuticals
Neurology 2003 61: S11-12. [Full Text] [Figures Only]  

Gavin Giovannoni
Strategies to treat and prevent the development of neutralizing anti-interferon-ß antibodies
Neurology 2003 61: S13-17. [Abstract] [Full Text] [Figures Only]  

Section II: Assays of antibodies to IFNβ:

Andrew R. Pachner, Joel Oger, and Jacqueline Palace
The measurement of antibodies binding to IFNß in MS patients treated with IFNß
Neurology 2003 61: S18-20. [Full Text] [Figures Only]  

Sidney E. Grossberg
Perspectives on the neutralization of interferons by antibody
Neurology 2003 61: S21-23. [Abstract] [Full Text] [Figures Only]  

Section III: MxA assays as measurements of IFN:

Andrew R. Pachner, Antonio Bertolotto, and Florian Deisenhammer
Measurement of MxA mRNA or protein as a biomarker of IFNß bioactivity: Detection of antibody-mediated decreased bioactivity (ADB)
Neurology 2003 61: S24-26. [Abstract] [Full Text] [Figures Only]  

Section IV: Experience of MS centers with anti-IFNβ antibodies:

Per Soelberg Sorensen
Antibodies to IFN-beta: The Danish National IFN-beta Project
Neurology 2003 61: S27-28. [Full Text] [Figures Only]  

Marcelo Kremenchutzky
Long-term evolution of anti-INFß antibodies in IFNß-treated MS patients: The London, Canada, MS Clinic experience
Neurology 2003 61: S29-30. [Full Text]  

Richard A. Rudick
Biologic impact of interferon antibodies, and complexities in assessing their clinical significance
Neurology 2003 61: S31-34. [Abstract] [Full Text] [Figures Only]  

A. John Petkau
Statistical approaches to assessing the effects of neutralizing antibodies: IFNß-1b in the pivotal trial of relapsing-remitting multiple sclerosis
Neurology 2003 61: S35-37. [Abstract] [Full Text] [Figures Only]  

Gary Cutter
Statistical issues in neutralizing antibodies
Neurology 2003 61: S38-39. [Full Text]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by AAN Enterprises, Inc.